Minapharm Pharmaceuticals (MIPH) Key Statistics
17 reported figures for Minapharm Pharmaceuticals — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 9.14B
- Dividend yield
- 0.31%
Income (latest fiscal year)
- Revenue
- EGP 5.66B
- Net income
- EGP 128.22M
- EBITDA
- EGP 982.65M
- Free cash flow
- EGP -652.19M
Balance sheet
- Total assets
- EGP 12B
- Total debt
- EGP 5.46B
Growth
- Revenue growth
- 45.55%
Per share
- EPS (fiscal year)
- 11.59
- Dividend per share
- 2.5
Technical
- RSI (14)
- 59.5
- 50-day moving average
- EGP 760.83
- 200-day moving average
- EGP 543.96
- Beta (1Y)
- 0.54
Shares
- Shares outstanding
- 11.78M
- Free float
- 42.13%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.